MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 112 filers reported holding MACROGENICS INC in Q1 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,957,000 | -12.9% | 420,000 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $2,247,000 | -25.4% | 420,000 | 0.0% | 0.00% | -25.0% |
Q1 2023 | $3,011,000 | +6.8% | 420,000 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $2,818,000 | +93.4% | 420,000 | -0.1% | 0.00% | +50.0% |
Q3 2022 | $1,457,000 | +17.2% | 420,490 | -0.2% | 0.00% | +100.0% |
Q2 2022 | $1,243,000 | -66.5% | 421,272 | 0.0% | 0.00% | -66.7% |
Q1 2022 | $3,711,000 | -45.1% | 421,272 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $6,761,000 | -23.5% | 421,272 | -0.2% | 0.01% | -25.0% |
Q3 2021 | $8,843,000 | -22.0% | 422,289 | 0.0% | 0.01% | -11.1% |
Q2 2021 | $11,342,000 | -15.5% | 422,289 | +0.2% | 0.01% | -52.6% |
Q1 2021 | $13,421,000 | +39.2% | 421,388 | -0.1% | 0.02% | +35.7% |
Q4 2020 | $9,642,000 | -9.3% | 421,813 | 0.0% | 0.01% | -22.2% |
Q3 2020 | $10,626,000 | -9.8% | 421,813 | 0.0% | 0.02% | -10.0% |
Q2 2020 | $11,777,000 | +635.6% | 421,813 | +53.4% | 0.02% | +566.7% |
Q1 2020 | $1,601,000 | -46.5% | 275,000 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $2,992,000 | -14.7% | 275,000 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $3,509,000 | -74.9% | 275,000 | -66.7% | 0.01% | -25.0% |
Q2 2019 | $14,001,000 | +199.5% | 825,000 | +217.3% | 0.01% | 0.0% |
Q1 2019 | $4,675,000 | +360.1% | 260,000 | +225.0% | 0.01% | +300.0% |
Q4 2018 | $1,016,000 | -40.8% | 80,000 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $1,715,000 | +3.8% | 80,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,652,000 | -17.9% | 80,000 | 0.0% | 0.00% | -25.0% |
Q1 2018 | $2,013,000 | +111.9% | 80,000 | +60.0% | 0.00% | +100.0% |
Q4 2017 | $950,000 | +2.8% | 50,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $924,000 | +5.5% | 50,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $876,000 | -5.8% | 50,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $930,000 | -9.0% | 50,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,022,000 | -14.5% | 50,000 | +25.0% | 0.00% | 0.0% |
Q3 2016 | $1,196,000 | -44.6% | 40,000 | -50.0% | 0.00% | 0.0% |
Q2 2016 | $2,160,000 | +188.0% | 80,000 | +100.0% | 0.00% | 0.0% |
Q1 2016 | $750,000 | – | 40,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
XTX Topco Ltd | 53,269 | $248,234 | 0.04% |